contentsicdm2016.diabetes.or.kr/file/announcement_3th.pdf · 2016-09-26 · the icdm has been...

Invitation

Timetable

Organization

Scientific program

Overview

Registration

Oral presentation / Poster exhibition

Floor plan

Accommodation

Transportation

3

4

6

7

15

26

27

28

30

31

CONTENTS

2016 International Conference on Diabetes and Metabolism · 3

Invitation

On behalf of the Korean Diabetes Association (KDA), it is our great honor to invite you to the 2016 International Conference on Diabetes and Metabolism (ICDM), which will be held in Seoul, Korea from October 13th to 15th, 2016, the most beautiful season in this country.

The ICDM has been successfully held with thousands of participants from the globe since its first inception in 2011. The 2016 ICDM will encompass a variety of up-to-date knowledge on diabetes and metabolism. There will be three plenary sessions, 14 main symposia, corporate symposia, and oral presentation. This year’s ICDM will be also featured by Best of EASD session and KDA-Steno session collaboratively organized by the KDA and Steno Diabetes Center of Denmark. Plenary speakers are world renowned scholars in the field of diabetes and metabolism, who will share their state-of-the-art knowledge and insight. In the main symposia, hot topics in various aspects of diabetes and metabolism from basic science to clinical therapeutics will be covered.

We would like to cordially invite you to join the 2016 ICDM. We believe, in this fabulous scientific meeting, that you can enjoy Seoul, home to beautiful historical sites, savory foods, internationally popular modern entertainments, and more.

We look forward to meeting you in the 2016 ICDM.

Sincerely yours

Yong-Wook Cho, M.D., Ph.D.

PresidentKorean Diabetes Association

Moon Kyu Lee, M.D., Ph.D.

Chairman, Board of DirectorsKorean Diabetes Association

Dear Colleagues,

4 · 2016 International Conference on Diabetes and Metabolism

Timetable

1st day (Thursday 13 October, 2016) Room Convention Hall A, 4F Convention Hall B, 4F Convention Hall C, 4F Emerald Hall A, 3F Emerald Hall B, 3F Hotel, 2F

Clinical diabetes and therapeutics

Behavioral medicine/education/Clinical nutrition/Self-care

Insulin action/Obesity/Integrated physiology Diabetic complications

Islet biology & insulin secretion/Epidemiology

& geneticsOral presentation Oral presentation Oral presentation Oral presentation

15:00-17:00Research group on Beta

Cell Biology and Islet Transplantation

Research group on Clinical Data Standardization for

Diabetes Research

Research group on Diabetic Neuropathy

Research group on Genetics

Research group on Diabetes in Old Age

17:00~17:30 Sulwon lecture

17:30~18:00 Satellite symposium1 Satellite symposium 2 Satellite symposium 3

18:00~ Welcome reception (Outdoor garden, 2F, Hotel)

2nd day (Friday 14 October, 2016)

07:30~08:30Breakfast symposium 1

(Grand Ballroom A, 2F, Hotel)

Breakfast symposium 2(Grand Ballroom C,

2F, Hotel)

09:00~11:00 S1 Clinical diabetes and therapeutics 1

*S2 Behavioral medicine/education S3 Insulin action S4 Diabetic

complications 1-AcuteS5 Islet biology & insulin secretion

11:00~11:20 Coffee break

11:20~11:30 Opening address

11:30~12:10 *Plenary lecture 1

12:10~12:30 Break (Poster viewing)

12:30~14:00 Luncheonsymposium 1

Luncheonsymposium 2

Luncheonsymposium 3

Luncheonsymposium 4


14:40~15:00 Coffee Break

15:00~16:00 Diabetes and Metabolism Journal session

Oral presentation 1 (Crane)

Oral presentation 2 (Swan)

Oral presentation 3 (White heron)

Oral presentation 4 (Flamingo)

16:00~18:00 S6 Clinical diabetes and therapeutics 2 *S7 Clinical nutrition KDA-Steno joint

symposiumS8 Diabetic

complications 2-ChronicS9 Epidemiology &

genetics

Committee of the Health

Insurance and Legislation

18:00~ Dinner and art performance (Grand ballroom, 2F, Hotel)

3rd day (Saturday 15 October, 2016)

07:00~08:00Breakfast symposium3



2F, Hotel)

08:30~10:30 S10 Clinical diabetes and therapeutics 3 *Committee of the Camp S11 Obesity Committee of Clinical

Practice GuidelineBest of EASD symposium 1





Luncheonsymposium 6

Luncheonsymposium 7

13:00~14:00 Oral presentation 5 (Crane)




14:00~16:00 Research group on Gestational Diabetes *S12 Self-care S13 Integrated physiology S14 Diabetic

complications 3-ChronicBest of EASD symposium 2

16:00~ Closing ceremony

Time

Session


1st day (Thursday 13 October, 2016) Room Convention Hall A, 4F Convention Hall B, 4F Convention Hall C, 4F Emerald Hall A, 3F Emerald Hall B, 3F Hotel, 2F

Clinical diabetes and therapeutics

Behavioral medicine/education/Clinical nutrition/Self-care

Insulin action/Obesity/Integrated physiology Diabetic complications

Islet biology & insulin secretion/Epidemiology

& geneticsOral presentation Oral presentation Oral presentation Oral presentation

15:00-17:00Research group on Beta

Cell Biology and Islet Transplantation

Research group on Clinical Data Standardization for

Diabetes Research

Research group on Diabetic Neuropathy

Research group on Genetics


17:00~17:30 Sulwon lecture

17:30~18:00 Satellite symposium1 Satellite symposium 2 Satellite symposium 3

18:00~ Welcome reception (Outdoor garden, 2F, Hotel)

2nd day (Friday 14 October, 2016)

07:30~08:30Breakfast symposium 1



2F, Hotel)

09:00~11:00 S1 Clinical diabetes and therapeutics 1

*S2 Behavioral medicine/education S3 Insulin action S4 Diabetic

complications 1-AcuteS5 Islet biology & insulin secretion


11:20~11:30 Opening address




Luncheonsymposium 2

Luncheonsymposium 3

Luncheonsymposium 4


14:40~15:00 Coffee Break

15:00~16:00 Diabetes and Metabolism Journal session

Oral presentation 1 (Crane)




16:00~18:00 S6 Clinical diabetes and therapeutics 2 *S7 Clinical nutrition KDA-Steno joint

symposiumS8 Diabetic

complications 2-ChronicS9 Epidemiology &

genetics

Committee of the Health

Insurance and Legislation

18:00~ Dinner and art performance (Grand ballroom, 2F, Hotel)

3rd day (Saturday 15 October, 2016)

07:00~08:00Breakfast symposium3



2F, Hotel)

08:30~10:30 S10 Clinical diabetes and therapeutics 3 *Committee of the Camp S11 Obesity Committee of Clinical

Practice GuidelineBest of EASD symposium 1





Luncheonsymposium 6

Luncheonsymposium 7

13:00~14:00 Oral presentation 5 (Crane)




14:00~16:00 Research group on Gestational Diabetes *S12 Self-care S13 Integrated physiology S14 Diabetic

complications 3-ChronicBest of EASD symposium 2

16:00~ Closing ceremony

* Sessions in Simultaneous Interpretation (EN to KR)


▼ Organizing committee

Chairman Moon Kyu Lee Co-Chairman Yong-Wook ChoSecretary general Jae Hyeon Kim Scientific program Kyong Soo ParkPublication Kyu Chang Won International liaison Sung Rae KimEducation Dong Jun Kim Public relation Dae Jung KimTreasurer Young Sun Hong Auditor Joong Yeol Park, Chul-Hee Kim

▼ Scientific program committee

▼ Local advisory board

▼ International advisory board

Chair Kyong Soo Park Secretary Young Min Cho Members In-Kyung Jeong Yang Ho Kang Hail Kim

Jae Hyeon Kim Jae Hyun Kim Jaetaek KimMin Seon Kim Nan Hee Kim Sang Yong KimYoung-Bum Kim Bo Kyung Koo Byung-Wan LeeDae Ho Lee Jung Hyun Noh Keun-Gyu ParkMin Ho Shong Jang Won Son Dae-Kyu Song

Members Hong-Sun Baek Bong Yun Cha Dong Seop ChoiYoung Kil Choi Min Young Chung Kap Bum HuhSung Koo Kang Bo Wan Kim Jin Woo KimKwang Won Kim Tae Wha Kim Yong Ki KimYoung-Kun Kim Young Seol Kim Sun Woo KimHong Kyu Lee Hyun Chul Lee Hun Ki MinSung Woo Park Ho Young Son Soon Hyun ShinnHyung Joon Yoo

E. Dale Abel Juliana C.N. Chan Robert A. HarrisAlicia Jenkins Linong Ji Takashi KadowakiItaru Kojima David D. Moore Wannee NitiyanantJianping Weng

Organization


15:00~17:00Convention hall A

Research group on Beta Cell Biology and Islet TransplantationIslet xenotransplantation: recent progress and current perspectivesRG1-1 Why islet xenotransplantation in diabetes?RG1-2 Islet xenotransplantation, past, present and future RG1-3 Avoidance strategy for xeonogenic immune reaction using highly advanced surface modification techniqueRG1-4 Xenotransplantation and zoonotic infection

Chairman : Kun-Ho Yoon

Kwang-Won Kim (Gachon University, Korea) Chung-Gyu Park (Seoul National University, Korea)

Jee-Heon Jeong (Yeungnam University, Korea)

Eung Soo Hwang (Seoul National University, Korea)

15:00~17:00Convention hall B

Research group on Clinical Data Standardization for Diabetes ResearchPlatforms for patient centered clinical researchRG2-1 Introduction of iCReaTRG2-2 ABLE: de-identified clinical data search, review, and extraction system

RG2-3 Introduction of KNDP data management house, KDMH

Chairman : Jeong Taek Woo

Hae Rim Choi (National Research Institute of Health, Korea)

Soo-Yong Shin (Kyung Hee University)Sang Youl Rhee (Kyung Hee University, Korea)

15:00~17:00Convention hall C

Research group on Diabetic NeuropathyParadigm shift of management in diabetic peripheral neuropathy RG3-1 Nonpharmacologic approach for managing diabetic polyneuropathy

RG3-2 Current update on pharmacologic management of diabetic neuropathy

RG3-3 Comprehensive management of intractable DPNRG3-Panel Panel discussion

Chairman : Tae Sun Park

Jee Youn Moon (Seoul National University, Korea)

Jee Young Oh (Konkuk University, Korea)Chong Hwa Kim (Sejong General Hospital, Korea)

Ji Hyun Lee (Daegu Catholic University, Korea), Jung Min Lee (The Catholic University of Korea, Korea),Mi Kyoung Park (Dong-A University, Korea)

15:00~17:00Emerald Hall A

Research group on GeneticsGenomics at the out-front of patient careRG4-1 Clinical whole exome sequencing in early onset diabetes patients

RG4-2 The physiology consequences of genetic variation in type 2 diabetes: the substrate balance hypothesis

RG4-3 Origins and functional consequences of mitochondrial DNA mutations in human cancer

RG4-4 Characteristics of apolipoprotein gene clusters on 11q23 and triglyceride levels in Asians

Chairman : Sung-Hoon Kim

Soo Heon Kwak (Seoul National University, Korea)

Richard M. Watanabe (University of Southern California, USA)

Young Seok Ju (KAIST, Korea)

Joohon Sung (Seoul National University, Korea)

15:00~17:00Emerald Hall B

Research group on Diabetes in Old AgeFrailty in diabetesRG5-1 The applications of individualized health management system using advanced medical information technology in elderly patients with diabetesRG5-2 Diabetes, vascular cognitive impairment and ADRG5-3 Frailty in diabetes

Chairman : Hyung Joon Yoo

Soo Lim (Seoul National University, Korea)Jee Hyang Jeong (Ewha Womans University, Korea)

Jung Hyun Noh (Inje University, Korea)

Thursday 13 October


Sulwon lecture Chairman : Young-Kun Kim

Scientific program



Satellite symposium 1 Sponsored by JW Pharmaceutical Novel DPP-4 inhibitor; anagliptin which improve hyperglycemia and ameliorate arterial stiffness

Chairman : Sung-Soo Koong

Yong-Ho Lee (Yonsei University, Korea)


Satellite symposium 2 Sponsored by Astellas Update on the safety of SGLT-2 inhibitor in elderly type 2 diabetes patients; focusing on ipragliflozin’s final analysis of STELLA-ELDER

Chairman : Duk Kyu Kim

Chong Hwa Kim (Sejong General Hospital, Korea)


Satellite symposium 3 Sponsored by PfizerThe latest updates in the management of dyslipidemia in the diabetes mellitus: what to consider what not

Chairman : Dong Sun Kim

Suk Chon (Kyung Hee University, Korea)

18:00Outdoor garden,2F, Hotel

Welcome reception

Friday 14 October

07:30~08:30Grand ballroom A, 2F, Hotel

Breakfast symposium 1 Sponsored by AstrazenecaBenefit your T2DM patients by early initiation of metformin/SGLT-2I combination treatment

Chairman : Hyun Chul Lee

Mi Kyung Kim (Inje University, Korea)

07:30~08:30Grand ballroom C, 2F, Hotel

Breakfast symposium 2 Sponsored by NovonordiskSWITCH: the answer to better glycaemic control safely

Chairman : Yong Ki Kim

Roger Chen (Concord Repatriation General Hospital, Australia)


S1 Clinical diabetes and therapeutics 1Updates on new drugs for type 2 diabetesS1-1 SGLT inhibition: is there a downside?

S1-2 Cardiovascular & renal outcomes of incretin-based therapy S1-3 GLP-1 receptor agonists: similarities and differencesS1-4 Ultra-long acting Insulin: How long should it be?

Chairman : Moon-Gi Choi, In Joo Kim

Merlin C Thomas (Baker IDI Heart and Diabetes Institute, Australia)Kyung Mook Choi (Korea University, Korea)

Chang Hee Jung (University of Ulsan, Korea)

Hyuk-Sang Kwon (The Catholic University of Korea, Korea)


S2 Behavioral medicine/educationCurrent management of type 1 diabetes in real clinical practiceS2-1 Clinical practice guidelines in management of type 1 diabetic patients

S2-2 Education programs for the better self-management of children and adolescents with type 1 diabetes S2-3 Dietary intervention in patients with type 1 diabetesS2-4 Psycosocial understanding and diabetes education for children with type 1 diabetes mellitus

Chairman : Doo Man Kim, Dong Jun Kim

Dong-Hyeok Cho (Chonnam National University, Korea)

Eun Kyung Kwon (Samsung Medical Center, Korea)Mi Ra Rho (Boramae Medical Center, Korea)

Myeoung Sook Lee (Dongsan Medical Center, Korea)

2



S5 Islet biology & insulin secretionToward beta cell replacement for diabetes S5-1 Maturation of human embryonic stem cell derived beta cells

S5-2 Differentiation of human induced pluripotent stem cells into insulin-producing cells

S5-3 Making mature human islet cells from stem cells to model disease and treat diabetes

S5-4 Glucose responsiveness of islet-like organoids generated from human pluripotent stem cells

Chairman : Sung-Hee Ihm, Ki-Ho Song

Metthias Hebrok (University of California San Francisco, USA)

Ji-Won Kim (The Catholic University of Korea, Korea)

Timothy Kieffer (University of British Columbia, Canada)

Yong-Mahn Han (KAIST, Korea)

11:00~11:203F & 4F Lobby

Coffee break


11:20~11:30Convention hall A, B, C

Opening address


Plenary lecture 1Cross-species genetic mapping of targets in metabolism and aging

Chairman : Yong-Wook Cho

Johan Auwerx (École Polytechnique Fédérale de Lausanne, Switzerland)


Luncheon symposium 1 Sponsored by Lilly Advances in the treatment of type 2 diabetes: a new once-weekly GLP-1 receptor agonist, dulaglutide

Chairman : Jin-Woo Kim

Kyu Yeon Hur (Sungkyunkwan University, Korea)


Luncheon symposium 2 Sponsored by Yuhan Empagliflozin: deep diving into EMPA-REG outcome (CV & renal)

Chairman : Ho Young Son Sung Hoon Yu (Hanyang University, Korea)


S4 Diabetic complications 1-AcuteImproving hypoglycemia in patients with diabetesS4-1 Incretin therapy and hypoglycemiaS4-2 Reversal of hypoglycemic unawareness with islet transplantation

S4-3 Updates in real-time CGM and artificial pancreasS4-4 Prevention of hypoglycemia-induced neuronal death

Chairman : Min Young Chung, Hyun Shik Son

Daisuke Yabe (Kyoto University, Japan)

Kun-Ho Yoon (The Catholic University of Korea, Korea )Sang-Man Jin (Sungkyunkwan University, Korea)

Sang Won Suh (Hallym University, Korea)


S3 Insulin actionmTOR and insulin action S3-1 Overview of mTOR signalingS3-2 mTOR signaling network in skeletal myogenesis S3-3 PHLPPs - necessary negative regulators of hepatic insulin signaling

S3-4 Control of adipogenesis by S6K1-mediated epigenetic modifications

Chairman : Sung Woo Park, Min ho Shong

Mee Sup Yoon (Gachon University, Korea)Jie Chen (University of Illinois, USA)

Utpal B. Pajvani (Columbia University, USA)

Jeung-Whan Han (Sungkyunkwan University, Korea)



Luncheon symposium 3 Sponsored by Sanofi Aventis Practical insulin titration: let your patient take the helm

Chairman : Kap Bum Huh Young Min Cho (Seoul National University, Korea)


Luncheon symposium 4 Sponsored by LG A new and powerful treatment option for dyslipidemia in type 2 diabetes mellitus

Chairman : You Hern Ahn

Eun-Gyoung Hong (Hallym University, Korea)

14:40~15:003F & 4F Lobby

Coffee break


Plenary lecture 2Metabolic surgery for type 2 diabetes: experience from Asia

Chairman : Moon-Kyu LeeWei-Jei Lee (Min-Sheng General Hospital, Taiwan)


S6 Clinical diabetes and therapeutics 2 Recent update on CVD risk management in type 2 diabetesS6-1 Management of cardiovascular disease in patients with diabetes S6-2 Update on blood pressure goals in T2DM (post-SPRINT era)S6-3 Are recent cholesterol treatment guidelines still controversial?S6-4 Obesity: drug or surgeryS6-5 Glucose control for prevention of cardiovascular disease (lesson from large clinical trials)

Chairman : Hyoung Woo Lee, Kyung Soo Ko

Bon-Kwon Koo (Seoul National University, Korea)Sung Ha Park (Yonsei University, Korea)Woo Je Lee (University of Ulsan, Korea)

Arya M. Sharma (University of Alberta, Canada)

Sang Yong Kim (Chosun University, Korea)


Diabetes and Metabolism Journal sessionSpecial oral session with DMJCS1-1 Normal glucose tolerance with a high 1-hour postload plasma glucose level exhibits decreased β-cell function similar to impaired glucose toleranceCS1-2 Changing clinical characteristics according to insulin resistance and insulin secretion in newly diagnosed type 2 diabetic patients in KoreaCS1-3 Cardiovascular disease predicts severe hypoglycemia in patients with type 2 diabetes

CS1-4 The insulin resistance but not the insulin secretion parameters have changed in the Korean population during the last decadeCS1-5 Insulin initiation in insulin naïve Korean type 2 diabetic patients inadequately controlled on oral antidiabetic drugs in real world practice: the modality of insulin treatment evaluation (MOTIV) study

Chairman : Kyu Chang Won, Won-Yoyng Lee

Tae Jung Oh (Seoul National University, Korea)

Jang Won Son (The Catholic University of Korea, Korea)

Jae-Seung Yun (The Catholic University of Korea, Korea)

Hae Kyung Yang (The Catholic University of Korea, Korea)

In Joo Kim (Pusan National University, Korea)


S7 Clinical nutrition Nutrition in diabetes preventionS7-1 Food, nutrient and risk of diabetesS7-2 Dietary components and nutritional strategies in the prevention and management of type 2 diabetes

S7-3 Theory-based nutrition intervention for preventing diabetesS7-4 Diabetes prevention in Australia: 10 years results and experience

Chairman : Hak Chul Jang, Kyu Jeung Ahn

Dae Jung Kim (Ajou University, Korea)

Yoon Ju Song (The Catholic University of Korea, Korea)Hyunjung Lim (Kyung Hee University, Korea)

James A Dunbar (Deakin University, Australia)


07:00~08:00Grand ballroom A, 2F, Hotel

Breakfast symposium 3 Sponsored by IldongNew anti-obesity drug

Chairman : Kwang-Won KimKyung Mook Choi (Korea University, Korea)

07:00~08:00Grand ballroom C, 2F, Hotel

Breakfast symposium 4 Sponsored by DaewoongThe optimized DPP-4 inhibitor for type 2 diabetes: focus on recent clinical results of gemigliptin in Korea

Chairman : Jae Myung Yu

Soo Lim (Seoul National University, Korea)

Saturday 15 October


KDA-Steno joint symposium Sponsored by Novo Nordisk®Gut microbiome and diabetes SI1-1 Omics, technologies and the diabetes clinic of the futureSI1-2 A potential role for the gut microbiota in diabetic kidney complications

SI1-3 The effect of host genetics on gut microbiota and metabolic syndromes

SI1-4 The impact of the gut microbiome on metabolic health and disease

SI1-5 Obesogenic diet-induced gut barrier dysfunction and pathobiont expansion cause metabolic syndrome and inflammatory bowel disease

Chairman : Moon-Kyu Lee, John J Nolan

John J Nolan (Steno Diabetes Center, Denmark)

Peter Rossing (Steno Diabetes Center, Denmark)

Gwang Pyo Ko (Seoul National University, Korea)

Torben Hansen (Copenhagen University, Denmark)

Kyu Yeon Hur (Sungkyunkwan University, Korea)

18:00Grand ballroom, 2F, Hotel

Dinner and art performance


S8 Diabetic complications 2-Chronic Novel experimental targets and therapeutic strategies for diabetic vascular complicationsS8-1 Diabetic kidney disease; past, present and futureS8-2 Discovery and development of PAI-1 inhibitors: potential clinical implications

S8-3 Mechanism of diabetic microvasculopathy, high jagged1 and low notch

S8-4 A toe in the door of translational research on diabetic retinopathy

Chairman : Dong-Seop Choi, Ki-Up Lee

Katalin Susztak (University of Pennsylvania, USA)

Toshio Miyata (Tohoku University, Japan)

Hyo-Soo Kim (Seoul National University, Korea)

Jeong Hun Kim (Seoul National University, Korea)


S9 Epidemiology & genetics Pharmacogenomics in type 2 diabetesS9-1 Pharmacogenomics and personalized drug therapyS9-2 Human genomic analysis of type 2 diabetes and its translation to clinical care

S9-3 Whole exome sequencing revealed variants associated with dependency on sulfonylureas in type 2 diabetes S9-4 Pharmacogenomics for the anti-platelet drug

Chairman : In-Kyu Lee, Taekeun Oh

Kyung-Sang Yu (Seoul National University, Korea)

Richard M. Watanabe (University of Southern California, USA)

Hye Seung Jung (Seoul National University, Korea)Su-Jun Lee (Inje University, Korea)



S10 Clinical diabetes and therapeutics 3 Staging and definition of metabolic diseaseS10-1 The edmonton obesity staging system to predict mortality

S10-2 Rationale and implications of a β-cell-centric classification of diabetes

S10-3 MHO (metabolically healthy obesity): reality or phantom?-pros; in view of reality

S10-4 MHO (metabolically healthy obesity): reality or phantom?-cons; is he a fancy cheater?

Chairman : Bong-Soo Cha, Arya M. Sharma

Arya M. Sharma (University of Alberta, Canada)

Stanley Schwartz (University of Pennsylvania, USA)

Sin Gon Kim (Korea University, Korea)

Sung Hee Choi (Seoul National University, Korea)


S11 ObesityCentral and peripheral interplay for energy and glucose metabolismS11-1 Control of glycemia by the CNSS11-2 Regulation of food intake by hypothalamic serotonin circuit S11-3 Gut-brain communication in the control of energy balance and glucose homeostasis

S11-4 Central dopaminergic system regulates energy balance and BAT function

Chairman : Yong Seong Kim, Soon Jib Yoo

Young-Bum Kim (Harvard University, USA)Jong Woo Shon (KAIST, Korea)

Gary J. Schwartz (Albert Einstein University, USA)

Ki Woo Kim (Yonsei-Wonju University, Korea)


Transition to adulthood in type 1 diabetesCS2-1 Cognitive behaviour therapy to improve psychosocial wellbeing in youth with type 1 diabetes

CS2-2 Transition to adult care for youth with type 1 diabetes

CS2-3 Management of adults with type 1 diabetes in Korea: today and tomorrow

CS2-4 A multicenter registry study of type 1 diabetes mellitusin Guangdong, China

Chairman : Sei Won Yang, Choon Hee Chung

Hye-Jung Shin (National Medical Center, Korea)

Fergus J. Cameron (University of Melbourne, Australia)

Jae Hyeon Kim (Sungkyunkwan University, Korea)

Daizhi Yang (Sun Yat-sen University, China)


Committee of Clinical Practice GuidelineClinical Guidelines for Diabetes in AsiaCS3-1 Screening and diagnosis of diabetes mellitus in Taiwan

CS3-2 Glycemic targets for elderly patients with diabetes in Japan

CS3-3 Cardiovascular disease risk estimation and lipid management in Chinese diabetes mellitus

CS3-4 Clinical practice guidelines to guide a system approach to diabetes care

CS3-5 The process of developing 2015 Clinical Practice Guideline of Korean Diabetes Association

Chairman : Young Seol Kim, Kyung Mook Choi

Hung-Yuan Li (National Taiwan University, Taiwan)

Masakazu Haneda (Asahikawa University, Japan)

Tao Yang (Nanjing University, China)

Ip Tim Lau (Tseung Kwan O Hospital, Hong Kong)

Seung-Hyun Ko (The Catholic University of Korea, Korea)


Best of EASD symposium 1 Sponsored by NovartisHighlights from 2016 EASD Annual Meeting SI2-1 The 3Ds: diabetes, depression and dementia–uncomfortable bedfellows

SI2-2 Lifestyle and type 2 diabetes; beyond glycemic control

Chairman : Sei Hyun Baik, Yeon-Ah Sung

Richard Holt (University of Southampton, UK)Michael Trenell (Newcastle University, UK)



S12 Self-carePatient-centered educational strategies for managing diabetesS12-1 From a physician-centered approach to story-centered care

S12-2 Community prediabetes/diabetes self-care education: nutrition, exercise & lifestyle change skills

Chairman : Bong Yun Cha, Jeong Rim Lee

Masatake Sugimoto (Tokyo Adventist Hospital, Japan)

Hannah Mitter (Circle of Community Health Educators International, USA)


Research group on Gestational DiabetesObesity & diabetes in pregnancy RG6-1 β-cell adaptation in obesity and pregnancyRG6-2 Prediction and prevention of gestational diabetes mellitus in obese women

RG6-3 Gestational weight gain in normal and diabetic pregnancy: it should be same or different?

RG6-4 Can metformin improve pregnancy outcomes in obese and diabetic women?

Chairman : Seok Won Park

Hail Kim (KAIST, Korea)

Kyung-Soo Kim (CHA University, Korea)

Min Hyoung Kim (Dankook University, Korea )

Kyung-Wook Kim (Dongtan Jeil Womens Hospital, Korea)



Luncheon symposium 5 Sponsored by Chongkundang Efficacy and safety of lobeglitazone/metformin combination

Chairman : Seong Yeon Kim

Jae Hyuk Lee (Seonam University, Korea)


Luncheon symposium 6 Sponsored by Takeda CV outcomes of alogliptin in T2DM patients: from free of CVD history to the highest-CV risk

Chairman : Young-Kil Choi

Hyuk-Sang Kwon (The Catholic University of Korea, Korea)


Luncheon symposium 7 Sponsored by Dong-A ST Efficacy and safety of the new DPP-4 inhibitor evogliptin

Chairman : Sung Koo KangJong Chul Won (Inje University, Korea)


Plenary lecture 3The role of pyruvate dehydrogenase kinases in regulation of mitochondrial function and metabolic flexibility

Chairman : Hong Kyu Lee

In-Kyu Lee (Kyungpook National University, Korea)

10:30~10:503F & 4F Lobby

Coffee break



Best of EASD symposium 2 Sponsored by NovartisHighlights from 2016 EASD Annual MeetingSI3-1 Overcoming the challenges of managing diabetes in pregnancy

SI3-2 Exercise and type 2 diabetes: movement as molecular medicine

Chairman : Kyoil Suh, Moon-Suk Nam

Richard Holt (University of Southampton, UK)

Michael Trenell (Newcastle University, UK)


S14 Diabetic complications 3-Chronic Deciphering diabetic complications one piece at a timeS14-1 Diabetic neuropathy in brain: time for a paradigm shiftS14-2 Extent & severity of coronary atherosclerosis in asymptomatic diabetic individuals

S14-3 My sweetheart is broken: role of glucose in diabetic cardiomyopathy

S14-4 Deficiency of endothelial transcription factor Sox17 causes intracranial aneurysm

Chairman : Joong Yeol Park, Jaetaek Kim

Seong-Su Moon (Dongguk University, Korea)

Eun Ho Choo (The Catholic University of Korea, Korea)

Adam R. Wende (University of Alabama at Birmingham, USA)

Seungjoo Lee (University of Ulsan, Korea)


S13 Integrated physiology Systemic control of energy balanceS13-1 Regulation of oxidative phosphorylation in diabetic nephropathy and in cancer: role of MEF2C-MYF5 and HRAS S13-2 Modulation of autophagy as a new therapeutic modality against metabolic syndrome

S13-3 Microbiota-generated metabolites improve muscle function via mitophagy

S13-4 Regulation of systemic glucose homeostasis by Th2 cytokines

S13-5 Targeting muscle PPARδ in metabolic syndrome

Chairman : Myung-Shik Lee, Dae Ho Lee

Rodrigue Rossignol (INSERM, France)

Myung-Shik Lee (Yonsei University, Korea)

Dongyeol Ryu (École Polytechnique Fédérale de Lausanne, Switzerland)

Min Ho Shong (Chungnam National University, Korea)

Weiwei Fan (The Salk Institute for Biological Studies, USA)


Overview

Plenary lecture 1

Plenary lecture 2

Plenary lecture 3

Johan AuwerxÉcole Polytechnique Fédérale de Lausanne, Switzerland

Wei-Jei LeeMin-Sheng General Hospital, Taiwan

In-Kyu LeeKyungpook National University, Korea

Dr. Johan Auwerx, Professor at the Ecole Polytechnique Fédérale, Lausanne, Switzerland, was trained as a physician scientist and has extensive research expertise and experience in cellular and molecular physiology, metabolism, and genetics. He has been at the forefront of systems biology and holistic approaches to map the signaling networks and pathways that govern metabolism. Dr. Auwerx has pioneered a unique and powerful cross-species genetic and multi-layered omics approach using cellular models, C.elegans, genetically engineered mouse models, mouse genetic reference populations, and human cohorts. This approach provided new and effective ways to identify and validate candidate genes and pathways involved in metabolic control with high clinical translational value.

Prof. Wei-Jei Lee is a very well renowned gastro-intestinal surgeon and clinical researcher. He commenced laparoscopic bariatric surgery for the treatment of severe obesity in 1997. He has contributed to the innovation of the treatment of type 2 diabetes by exploiting laparoscopic gastro-intestinal surgery also known as metabolic surgery from 2005. He is one of the expert committee members for the recent guidelines of metabolic surgery for type 2 diabetes. In this lecture, he will share his data and perspectives on metabolic surgery in Asian patients with type 2 diabetes.

Prof. In-Kyu Lee is a professor of internal medicine, Kyungpook National University School of Medicine. His major research interest is focused on the role of mitochondrial enzyme pyruvate dehydrogenase complex (PDC) and its kinase (pyruvate dehydrogenase kinase) in diabetes and insulin resistance. In this plenary lecture, he will share his recent discoveries which highlight the importance of PDC flux in cellular energy metabolism and its potential application in strategies to ameliorate insulin resistance and associated pathological conditions.

Cross-species genetic mapping of targets in metabolism and aging

Metabolic surgery for type 2 diabetes: experience from Asia

The role of pyruvate dehydrogenase kinases in regulation of mitochondrial function and metabolic flexibility

Friday 14 October / 11:30~12:10 / Convention hall A, B, C

Friday 14 October / 14:00~14:40 / Convention hall A, B, C

Saturday 15 October / 10:50~11:30 / Convention hall A, B, C


Merlin C ThomasBaker IDI Heart and

Diabetes Institute, Australia

Kyung Mook ChoiKorea University, Korea

Chang Hee JungUniversity of Ulsan, Korea

Hyuk-Sang KwonThe Catholic University of Korea,

Korea

Dong-Hyeok ChoChonnam National University,

Korea

Kyung MookKorea University, Korea

Eun Kyung KwonSamsung Medical Center,

Korea

Myeoung Sook LeeDongsan Medical Center,

Korea

Mee Sup YoonGachon University, Korea

Jie Chen ChoiUniversity of Illinois, USA

Utpal B. PajvaniColumbia University, USA

Jeung-Whan HanSungkyunkwan University,

Korea

This symposium will introduce the recent updates in the field of new drugs for type 2 diabetes, including SGLT2 inhibitor, GLP-1 receptor agonist and ultra-long acting insulin. In the first topic, professor Merlin C Thomas will present about SGLT2 inhibition and the potential for renal protection in type 2 diabetes. Next, professor Kyung-Mook Choi, Korea University, will discuss the cardiovascular and renal outcomes of incretin-based therapy. In the third part, professor Chang Hee Jung, University of Ulsan College of Medicine, will discuss about the properties of short- and long-acting GLP-1 analogs. Lastly, professor Hyuk-Sang Kwon, the Catholic University of Korea, will talk about concepts and clinical use of new-generation ultra-long-acting basal insulin, and the possible disadvantage in its use.

Type 1 diabetic patients have different clinical characteristics and natural courses compared to type 2 diabetics and these differences require different standards of care. The management of type 1 diabetes must take the major differences between children of various ages and adults into account. In this session, four speakers with a volume of experience in the field of management of type 1 diabetes will deliver a lecture, focused on real clinical practice (general management guideline, educational programs for improving self-management, dietary intervention, and psychosocial understanding). Please join us for this session and enjoy the exciting discussion.

The critical role of mTOR signaling in regulating metabolic stress has received intensive attention. In this session, new understandings of mTOR signaling in major insulin-sensitive tissues with a particular emphasis on its pathophysiologic relevance will be reviewed. Professor Prof. Mee Sup Yoon (Gachon Univ. Korea) will open the session by reviewing mTOR pathways to guide the audience. Prof. Jie Chen Choi (UIUC, IL) will address multiple signaling pathways sensing amino acids upstream of mTOR for the regulation of myogenesis. Dr. Pajvani (Columbia University, NY) will show new data on the role of mTORC1-independent free Raptor on hepatic Akt activity and lipogenesis. Prof. Jeung-Whan Han (Sungkyunkwan University, Korea) will present that S6K1 suppress Wnt gene expression and drive adipogenesis via epigenetic regulatory mechanisms after adipogenic stimulation.

Updates on new drugs for type 2 diabetes

Current management of type 1 diabetes in real clinical practice

mTOR and insulin action

S1 Clinical diabetes and therapeutics 1

S2 Behavioral medicine/education

S3 Insulin action

Friday 14 October / 09:00~11:00 / Convention hall A

Friday 14 October / 09:00~11:00 / Convention hall B

Friday 14 October / 09:00~11:00 / Convention hall C

Organizer : Jung Hyun Noh, Jang Won Son

Organizer : Committee of Education

Organizer : Dae Ho Lee


Daisuke YabeKyoto University, Japan

Kun-Ho YoonThe Catholic University of

Korea, Korea

Sang-Man JinSungkyunkwan University,

Korea

Sang Won SuhHallym University, Korea

Metthias HebrokUniversity of California San

Francisco, USA

Ji-Won KimThe Catholic University of

Korea, Korea

Timothy KiefferUniversity of British Columbia,

Canada

Yong-Mahn HanKAIST, Korea

Hypoglycemia is recognized to be one of the strongest predictors of adverse clinical outcomes including macrovascular events and mortality in patients with diabetes; it is a major limiting factor in tight glycemic management of diabetes. At first in this session, Professor Daisuke Yabe (Kyoto University, Japan) will introduce safety issues of incretin therapy focused on hypoglycemia. For hypoglycemia-unawareness in type 1 diabetes, islet Transplantation and real-time continuous glucose monitoring will be discussed by Professors Kun-Ho Yoon (The Catholic University, Korea) and Sang-Man Jin (Sungkyunkwan University, Korea). In addition, neuronal damage associated with hypoglycemia will be dealt in depth by Professor Sang Won Suh (Hallym University, Korea).

A decrease in the functional beta cell mass is the key feature of both type 1 and type 2 diabetes. Thus, recovery of functional beta cell mass is thought to be a possible therapeutic strategy to cure diabetes. Recently, technology to induce beta cell differentiation from stem cells is rapidly developing and will be the new source of beta cells for transplantation. In this session, four outstanding speakers will share their recent progress on beta cell differentiation from stem cells.

Improving hypoglycemia in patients with diabetes

Toward beta cell replacement for diabetes

S4 Diabetic complications 1-Acute

S5 Islet biology & insulin secretion

Friday 14 October / 09:00~11:00 / Emerald Hall A

Friday 14 October / 09:00~11:00 / Emerald Hall B

Organizer : Bo Kyung Koo

Organizer : Hail Kim, Jae Hyeon Kim, Dae-Kyu Song

Bon-Kwon KooSeoul National University,

Korea

Sung Ha ParkYonsei University, Korea

Woo Je LeeUniversity of Ulsan, Korea

Arya M. SharmaUniversity of Alberta, Canada

Sang Yong KimChosun University, Korea

Cardiovascular disease (CVD) is the leading cause of mortality and morbidity for patients with type 2 diabetes. Numerous studies have shown the benefit of controlling individual CV risk factors such as hyperglycemia, hypertension, dyslipidemia, obesity in preventing CVD. Recent major new clinical studies and guidelines may now change the landscape of CV risk management of T2DM. This session will deal with the contents from the basic knowledge for CV management to latest updates on the management of each CVD risk factors. Prof. Bon-Kwon Ku (cardiologist from Seoul National University) will open the session by an overview of the comprehensive management of CVD in type 2 diabetes which is imperatively necessary for diabetologist. Prof. Sung Ha Park (cardiologist from Yonsei University) will present the update on blood pressure goals since the data of SPRINT study was published. Prof. Woo Je Lee (diabetologist from University of Ulsan) will address the changes of management of dyslipidemia after new ACC/AHA dyslipidemia guideline. Prof. Arya M. Sharma (University of Alberta) will give a lecture about management of obesity that whether the pharmacologic treatment or surgical treatment is more helpful for obese T2DM patient. Professor Sang Youg Kim (diabetologist from Chosun University) will show the lesson from large clinical extension trials about glucose control and cardiovascular outcomes. This multidisciplinary session will be of interest to you.

Recent update on CVD risk management in type 2 diabetes

S6 Clinical diabetes and therapeutics 2 Friday 14 October / 16:00~18:00 / Convention hall A

Organizer : In-Kyung Jeong, Yang Ho Kang


Katalin SusztakUniversity of Pennsylvania,

USA

Toshio MiyataTohoku University, Japan

Hyo-Soo KimSeoul National University,

Korea

Jeong Hun KimSeoul National University,

Korea

Kyung-Sang YuSeoul National University,

Korea

Richard M. WatanabeUniversity of Southern

California, USA

Hye Seung JungSeoul National University,

Korea

Su-Jun LeeInje University, Korea

Dae Jung KimAjou University, Korea

Yoon Ju SongThe Catholic University of

Korea, Korea

Hyunjung LimKyung Hee University, Korea

James A DunbarDeakin University, Australia

This session will focus on the new experimental and therapeutic strategies for preventing and treating diabetic vascular complications. Prof. Susztak from University of Pennsylvania will summarize her basic research and genomic and epigenomic studies. She will also provide next generation therapeutics for chronic kidney disease. Prof. Miyata from Tohoku University will present his recent discovery about new PAI-1 inhibitor to retard diabetic vascular complications as well as aging. Prof. Hyo-Soo Kim in Seoul National University will talk about Notch signaling, which is a new pathophysiologic mechanism in diabetic microvascular complications. Finally, Prof. Jeong Hun Kim from Seoul National University will raise concerns related anti-VEGF antibody treatment in diabetic retinopathy and provide some recent results to overcome them, such as targeting HIFs.

Individual traits that affect response to specific drugs have a key role in personalized diabetes management. Rapid advances in knowledge of patient-specific pharmacology occur via the application of new molecular technology in gene-focused (pharmacogenetics) and genome-wide (pharmacogenomics) analyses. Prof. Kyung-Sand Yu (Seoul National University, Korea) will provide the overview for pharmacogenomics and personized drug therapy. Subsequently, Prof. Richard Watanebe (University of Southern California, USA), Prof. Hy Seung Jung (Seoul National University, Korea), and Prof. Su-Jun Lee (Inje University, Korea) will give us lectures on the personized medicine more specifically focusing on PPAR-gamma, sulfonylurea and anti-platelet agents, respectively.

Type 2 diabetes mellitus is preventable disease and many studies show that people at high risk for diabetes can prevent or delay the onset of diabetes by intensive lifestyle modification programs. Now, the Ministry of Health and Welfare of Korea and Korean Diabetes Association are working together to make a Korean national program for diabetes prevention. In this session, Prof. Dae Jung Kim (Ajou University, Korea) will present about the food and nutrient as a risk for diabetes, Prof. Yoon Ju Song (Catholic University, Korea) will discuss the nutritional strategy for diabetes prevention, Prof. Hyunjung Lim (Kyung Hee University, Korea) will introduce a new education program based behavior-change theory and Prof. James A Dunbar (Deakin University, Australia) will share and discuss the results and experience of 10 year diabetes prevention study in Australia.

Novel experimental targets and therapeutic strategies for diabetic vascular complications

Pharmacogenomics in type 2 diabetes

Nutrition in diabetes prevention

S8 Diabetic complications 2-Chronic

S9 Epidemiology & genetics

S7 Clinical nutrition

Friday 14 October / 16:00~18:00 / Emerald Hall A

Friday 14 October / 16:00~18:00 / Emerald Hall B

Friday 14 October / 16:00~18:00 / Convention hall B

Organizer : Nan Hee Kim

Organizer : Jae Hyun Kim

Organizer : Committee of Food and Nutrition


Arya M. SharmaUniversity of Alberta, Canada

Stanley SchwartzUniversity of Pennsylvania,

USA

Sin Gon KimKorea University, Korea

Sung Hee ChoiSeoul National University,

Korea

The definition of a disease changes over time. Based on the disease definition, we use disease staging as a classification system that uses diagnostic findings to produce clusters of patients who require similar treatment and have similar expected outcomes. Because metabolic disorders including obesity and type 2 diabetes (T2D) are heterogenous and influenced by social and economic environment, the definition and staging system of disease might be changed or progressed. For better understanding and giving insight on clustering of clinically homogeneous patients for assessment of quality of care, analysis of clinical outcomes, review of utilization of resources, and assessment of efficacy of alternative treatments, we invited 4 distinguished speakers to solve these matters.

Staging and definition of metabolic disease

S10 Clinical diabetes and therapeutics 3 Saturday 15 October / 08:30~10:30 / Convention hall A

Organizer : Sang Yong Kim, Byung-Wan Lee

Young-Bum KimHarvard University, USA

Jong Woo ShonKAIST, Korea

Gary J. SchwartzAlbert Einstein University, USA

Ki Woo KimYonsei-Wonju University,

Korea

Recent evidence suggests that intimate communication between the central nervous system and peripheral metabolic organs is critical for the homeostatic control of energy balance and blood glucose levels. This session has four outstanding speakers from the United States and Korea. The first speaker Prof. Young-Bum Kim from the Harvard Medical School will present how the brain controls blood glucose levels. The second speaker Prof. Jong Woo Shon from the Korean Advanced Institute of Science and Technology will present the mechanism of feeding regulation through the hypothalamic serotonergic circuit. The third speaker Prof. Gary Schwartz will talk about the importance of gut afferent system in delivering nutritional information to the brain. Finally, Prof. Ki-Woo Kim at the Yonsei-Wonju University will present his recent findings on the regulation of energy balance and brown adipose tissue thermogenesis by central dopaminergic system.

Central and peripheral interplay for energy and glucose metabolism

S11 Obesity Saturday 15 October / 08:30~10:30 / Convention hall C

Organizer : Min Seon Kim

Masatake SugimotoTokyo Adventist Hospital,

Japan

Hannah MitterCircle of Community Health

Educators International, USA

In this self-care session, we will have two distinguished speakers. Dr. Masatake Sugimoto from Japan will explain how important it is for medical practitioners to switch their viewpoint from ‘a doctor manages their patient’ to ‘a patient manages their diabetes’. Dr. Hannah Mitter from U.S.will discuss how community health educators, including physicians, nurses, dietitians, nutritionists, other medical professionals, and trained non-medical personnel can participate community lifestyle intervention programs.

Patient-centered educational strategies for managing diabetes

S12 Self-care Saturday 15 October / 14:00~16:00 / Convention hall B

Organizer : Korean Association Diabetes Nurse Educators


Seong-Su MoonDongguk University, Korea

Eun Ho ChooThe Catholic University of Korea,

Korea

Adam R. WendeUniversity of Alabama at

Birmingham, USA

Seung Joo LeeUniversity of Ulsan, Korea

Kwang-Won KimGachon University, Korea

Chung-Gyu ParkSeoul National University,

Korea

Jee-Heon JeongYeungnam University, Korea

Eung Soo HwangSeoul National University,

Korea

Rodrigue RossignolINSERM, Francen

Myung-Shik LeeYonsei University, Korea

Dongyeol RyuÉcole Polytechnique Fédérale de

Lausanne, Switzerland

Min Ho ShongChungnam National University,

Korea

Weiwei FanThe Salk Institute for Biological

Studies, USA

Diabetes dramatically increases the risk of various cardiovascular complications, including coronary artery disease, stroke, and atherosclerosis. In this session, four prominent researchers will give lectures about recent advances in diabetes-associated nervous and cardiovascular consequences. Prof. Seong-Su Moon, from Dongguk University, will present recent advances focused on the brain and diabetic neuropathy. Prof. Eun Ho Choo, from The Catholic University of Korea, will focus on the extent and severity of coronary atherosclerosis in asymptomatic diabetic individuals evaluated by coronary CT angiography. Prof. Adam R. Wende, from University of Alabama at Birmingham, will present emerging evidence for epigenetic transcriptional regulation in diabetic cardiomyopathy. Prof. Seungjoo Lee, from department of neurosurgery in University of Ulsan, will deliver a lecture on the mechanism by which the endothelium-specific transcription factor Sox17 regulates vascular homeostasis.

Over the last 15 years, islet allotransplantation has evolved into an established treatment for type 1 diabetic patients with hypoglycemic unawareness, and the procedure is currently reimbursed for this indication in several countries. However, human islet allotransplantation will never supply sufficient islets for the treatment of the many millions of patients with type 1 diabetes. Preliminary safety data obtained in recent pilot clinical trials, and preclinical safety and efficacy data obtained in the last 10 years in the stringent pig-to-nonhuman primate islet xenotransplantation setting, suggest that xenogeneic porcine islets can possibly be developed an alternative β-cell replacement therapy with broad applicability. In addition, the recent results reveal the potential impact of genetic modification of the xenogeneic islet donor and offer promise that an unlimited source of transplantable β-cells may be possible. In this session, recent progress and current perspective of islet xenotransplantation will be discussed.

Recently, many pathophysiological mechanisms have been suggested for links between metabolic diseases and an impaired control of energy balance, including gut microbiota, autophagy and immune response. In this session, 5 outstanding speakers will cover each issue. For the first topic, Prof. Rossignol from INSERM will talk about bioenergetic modulation in rare and common disease. Next, Prof. Lee from Yonsei University will talk the effect of autophagy modulation on the whole body metabolism. Thirdly, Dr. Ryu from EPFL will introduce the recent progress on the role of gut microbiota metabolites on host health. Fourthly, Prof. Shong from Chungnam University will share the current understanding about the critical role of Th2 cytokines in systemic glucose homeostasis. Lastly, Dr. Fan from Salk Institute will talk about the role of PPARδ in muscle and its potential implication in metabolic syndrome.

Deciphering diabetic complications one piece at a time

Islet xenotransplantation: recent progress and current perspectives

Systemic control of energy balance

S14 Diabetic complications 3-Chronic

Research group on Beta Cell Biology and Islet Transplantation

S13 Integrated physiology

Saturday 15 October / 14:00~16:00 / Emerald Hall A

Thursday 13 October / 15:00~17:00 / Convention hall A

Saturday 15 October / 14:00~16:00 / Convention hall C

Organizer : Jaetaek Kim

Organizer : Research group on Beta Cell Biology and Islet Transplantation

Organizer : Young Min Cho, Keun-Gyu Park, Min Ho Shong


Hae Rim ChoiNational Research Institute of

Health, Korea

Soo-Yong ShinKyung Hee University, Korea

Sang Youl RheeKyung Hee University, Korea

Recently, patient registration based clinical, and translational research such as Precision Medicine Initiative have been actively conducted in worldwide. In Korea, there have been managed several relevant systems for large-scale, multi-center, patient data registration and management. This session is organized to introduce major patient registration systems for diabetes and related metabolic diseases in Korea, and to spread relevant knowledge, knowhow, and information for cooperative research.

Platforms for patient centered clinical research

Research group on Clinical Data Standardization for Diabetes ResearchThursday 13 October / 15:00~17:00 / Convention hall B

Organizer : Research group on Clinical Data Standardization for Diabetes Research

Jee Youn MoonSeoul National University,

Korea

Jee Young OhKonkuk University, Korea

Chong Hwa KimSejong general hospital, Korea

Diabetic peripheral neuropathy (DPN) is the most common complication of diabetes mellitus (DM), affecting as many as 50% of patients with type 2 DM in Korea. Diabetic peripheral neuropathy involves the presence of symptoms or signs of peripheral nerve dysfunction and decreased quality of life in people with DPN. Management of DPN involves nonpharmacologic and pharmacologic approaches to minimize disease progression and relieve symptoms. This hot topic will be covered by 3 distinguished speakers and discussed with panelists (Ji Hyun Lee, Jung Min Lee , Mi Kyoung Park).

Paradigm shift of management in diabetic peripheral neuropathy

Research group on Diabetic Neuropathy Thursday 13 October / 15:00~17:00 / Convention hall C

Organizer : Research group on Diabetic Neuropathy

Soo Heon KwakSeoul National University,

Korea

Richard M. WatanabeUniversity of Southern

California, USA

Young Seok JuKAIST, Korea

Joo Hon SungSeoul National University,

Korea

Genome analysis techniques using next generation sequencing and genome-wide association studies have made great strides in the past 10 years. Using these technique, extensive research has been conducted on the genetic predisposition for diabetes. It is widely accepted that genomic information will be a critical component of precision medicine in a very near future. The KDA interest group on genetics organized a meeting to share the results and experiences from the recent studies by the researchers on the out-front of such advancement. Dr. Soo-Heon Kwak at Seoul National University Hospital will share his experience on using whole exome sequencing for diagnosis of monogenic diabetes. Dr. Richard M. Watanabe at Keck School of Medicine of University of Southern California will give a lecture on current research on genetics of diabetes. Dr. Young Seok Ju at Korea Advanced Institute of Science and Technology will present on genetic investigation using mitochondrial DNA variation. Finally, Dr. Joohon Sung at Seoul National University will present his latest work on characteristics of Apolipoprotein gene clusters on chromosome 11 and the association with plasma triglyceride level. The four speakers will share their recent works as well as their views on incorporating genetic information in clinical research and practice.

Genomics at the out-front of patient care

Research group on Genetics Thursday 13 October / 15:00~17:00 / Emerald Hall A

Organizer : Research group on Genetics


Soo LimSeoul National University,

Korea

Jee Hyang JeongEwha Womans University,

Korea

Jung Hyun NohInje University, Korea

Hail KimKAIST, Korea

Kyung-Soo KimCHA University, Korea

Min Hyoung KimDankook University, Korea

Kyung Wook KimDongtan Jeil Womens

Hospital, Korea

Tae Jung OhSeoul National University,

Korea

Jang Won SonThe Catholic University of

Korea, Korea

Jae Seung YunThe Catholic University of

Korea, Korea

Hae Kyung YangThe Catholic University of

Korea, Korea

In Joo KimPusan National University,

Korea

Aging is a significant driver of the diabetes epidemic. Although diabetes in older adults is linked to higher mortality and reduced functional status, we still do not know the risk of old diabetes. In this session, we focus on the pathogenesis of diabetes in the aging population. Prof. Soo Lim (Seoul National University, Korea) is going to open the session by reviewing diabetes in aging population to help you to understand the elderly diabetes. Prof. Jee Hyang Jeong (Ewha Womans University, Korea) will address cognitive impairment and Alzheimer’s disease resulting from elderly diabetes. Prof. Jung Hyun Noh (Inje University, Korea) will present critical information regarding the frailty of elderly diabetes.

The research group on gestational diabetes in Korean Diabetes Association set various topics related to obesity and diabetes in pregnancy. Four researchers who are actively conducting studies in this field were selected to share the latest information and their expertise in this session. Prof. Hail Kim from KAIST, Korea, will present about β-cell adaptation in obesity and pregnancy. Prof. Kyung-Soo Kim from CHA University, Korea, will give a lecture on how to predict and prevent gestational diabetes mellitus in obese women. Prof. Min Hyoung Kim from Dankook University, Korea, will discuss whether gestational weight gain in normal and diabetic pregnancy is same or not. Dr. Kyung Wook Kim from Dongtan Jeil Womens Hospital, Korea, will summarize the studies for metformin use on pregnant women with obesity and diabetes.

The Diabetes & Metabolism Journal (DMJ), the official journal of Korean Diabetes Association (KDA), publishes articles on basic and clinical studies, focusing on areas such as metabolism, epidemiology, pathogenesis, complications, and treatments relevant to diabetes mellitus bimonthly. It also publishes articles covering obesity and cardiovascular disease. The Committee of Publication of KDA has selected the best articles among papers published in DMJ in 2015. In this session, the authors of the selected articles will share results of their outstanding researches.

Frailty in diabetes

Obesity & diabetes in pregnancy

Special oral session with DMJ


Research group on Gestational Diabetes

Diabetes and Metabolism Journal session

Thursday 13 October / 15:00~17:00 / Emerald Hall B

Saturday 15 October / 14:00~16:00 / Convention hall A

Friday 14 October / 15:00~16:00 / Convention hall A

Organizer : Research group on Diabetes in Old Age

Organizer : Research group on Gestational Diabetes

Organizer : Committee of Publication


Hye-Jung ShinNational Medical Center, Korea

Fergus J. CameronUniversity of Melbourne,

Australia

Jae Hyeon KimSungkyunkwan University,

Korea

Daizhi YangSun Yat-sen University, China

Hung-Yuan LiNational Taiwan University,

Taiwan

Masakazu HanedaAsahikawa University, Japan

Tao YangNanjing University, China

Ip Tim LauTseung Kwan O Hospital,

Hong Kong

Seung-Hyun KoThe Catholic University of

Korea, Korea

John J NolanSteno Diabetes Center,

Denmark

Peter RossingSteno Diabetes Center,

Denmark

Gwang Pyo KoSeoul National University,

Korea

Torben HansenCopenhagen University,

Denmark

Kyu Yeon HurSungkyunkwan University,

Korea

Emerging adults with type 1 diabetes are at risk for poor glycemic control, gaps in medical care, and adverse health outcomes. There are many challenges that face the emerging young adult with type 1 diabetes. The transition to adult medical care has long been defined as “the purposeful, planned movement of adolescents and young adults from child-centered to adult-centered health care systems.” In recent years, the topic of transitioning pediatric patients with type 1 diabetes to adult diabetes care has been discussed in the literature and there have been many studies. This session will deal with the recent progress on transition and management to adulthood in type 1 diabetes.

Most of the Asian countries still accept the clinical practice recommendations for diabetes mellitus based on the evidence from western people. However, we are in desperate need of different, and optimized clinical practice recommendations for Asian diabetes mellitus based on the evidence from Asian people. The Committee of Clinical Practice Guideline of KDA published “2015 Clinical Practice Guidelines for Diabetes in Korea” last year. At this juncture, KDA invites speakers from 5 Asian countries to share and discuss their own guidelines. This session will be a meaningful start for the consensus for clinical practice guidelines for diabetes in Asia.

This particular session is organized by the collaboration between the Korean Diabetes Association (KDA) and world renowned Steno Diabetes Center in Copenhagen, Denmark. This session will provide participants with the latest advances and perspective on gut microbiome and metabolic alterations. Three speakers from Steno Diabetes Center and two speakers from Korea will share their data and perspectives on gut microbiome. We also believe that this symposium will serve as a distinctive opportunity to initiate a firm alliance to fight diabetes and promote friendship between KDA and Steno Diabetes Center.

Transition to adulthood in type 1 diabetes

Clinical Guidelines for Diabetes in Asia

Gut microbiome and diabetes

Committee of the camp

Committee of Clinical Practice Guideline

KDA-Steno joint symposium

Saturday 15 October / 08:30~10:30 / Convention hall B

Saturday 15 October / 08:30~10:30 / Emerald Hall A

Friday 14 October / 16:00~18:00 / Convention hall C

Organizer : Committee of Camp

Organizer : Committee of Clinical Practice Guideline

Organizer : Committee of Scientific Affairs


Richard HoltUniversity of Southampton,

UK

Michael TrenellNewcastle University, UK

The aims of the EASD are to encourage and support research in the field of diabetes, the rapid diffusion of acquired knowledge and to facilitate its application. The EASD is pleased to bring key presentations to countries around the world through the Best of EASD programmes. The presentations from renowned European speakers are designed to help increase your knowledge of and confidence in treating diabetes. We are proud to bring you this professional education programme organized in cooperation with the Korean Diabetes Association (KDA) and focused on providing new and relevant information that was presented at the EASD Annual Meeting in Munich this year.

Highlights from 2016 EASD Annual Meeting

Best of EASD symposium Saturday 15 October / 08:30~10:30 & 14:00~16:00 / Emerald Hall B

Organizer : Committee of Scientific Affairs


Registration

The registration desk is located at the lobby, 4F, Convention center.Please be sure to complete registration procedures before accessing to any of the conference sessions and events.

Be sure to remember your registration number and name.

• It is possible to make registration onsite.

Below materials are offered to registrants

• 13 October 2016: 13:00 - 17:00• 14 October 2016: 07:30 - 17:00• 15 October 2016: 07:00 - 14:00

* Regular rate: Medical doctors, Scientists* Reduced rate: Healthcare professionals other than medical doctors (nurses, dietitian, pharmacist, others),

Residents, Students* Low income countries https://datahelpdesk.worldbank.org/knowledgebase/articles/906519* Dinner Date & Time: [18:00~] 14 October Fee: USD 20 per one person

ClassificationOn-site registration 13~15 October 2016

DomesticInternational

Member Non-ember

Regular rateFull registration USD 120 USD 170 USD 200

One-day registration USD 100 USD 140 USD 150

Reduced rateUSD 70 USD 90 USD 150

Low income countries : USD 50

Place Registration desk Abstract book desk

Materials Badge, Lanyards Bag, Abstract book

* Note: Registrants are strongly requested to wear name badge during the conference.

Category Place

Invited speaker & chairman KDA booth

Domestic (inclusive of oral presenting authors) Registration desk for Domestic

International (inclusive of oral presenting authors) Registration desk for International

▼ Early registration

▼ On-site registration

▼ Conference kit

▼ Work hour

▼ Registration place


Oral presentation / Poster exhibition

Presenting authors are recommended to check their assigned presentation number and schedule be referring to the below information.

Date & Time / Place Crane, Hotel, 2F Swan, Hotel, 2F White heron, Hotel, 2F Flamingo, Hotel, 2F

Friday 14 October15:00~16:00

Oral presentation 1

Behavior, nutrition, education & exercise

Oral presentation 2

Clinical diabetes

Oral presentation 3

Epidemiology / genetics

Oral presentation 4

Insulin secretion and action & Integrated

physiology / obesity 1

Saturday 15 October13:00~14:00

Oral presentation 5

Macrovascular & Microvascular complications

Oral presentation 6

Metabolic syndrome & prediabetes

Oral presentation 7

Therapeutics of diabetes

Oral presentation 8

Insulin secretion and action & Integrated

physiology / obesity 2

▼ Oral presentation

▼ Poster exhibitions

• Date : 14 ~ 15 October• Place : Diamond hall, 3F, Convention center• Mounting : Before 9:00, 14 October 2016• Removal : After 16:00, 15 October 2016• Poster size : 90cm (W) X 140cm (L)• Language : English• Note : Posters are asked to be kept onto the boards during the whole of conference.


Floor plan

2F, Hotel / 4F, Convention center

3F, Convention center ▶

▶

2F, Hotel

Flamlngo

WhiteHeron

Sky lark

Swan

Crane

A

A

B

B

C

Diamondhall

Peacock Grand ballroomC

Grand ballroomB

Grand ballroomA

4F, Convention center

Board room

Convention hall

Emerald hall

Meeting room

Oral presentation

Committee meeting room

Preview room

KDA booth

Registration

Abstract book desk

VIP room

Meeting room

Poster exhibition

KDA lounge

Information

Welcome reception


1F, Convention center

▶

Corporate booths

Luggage

Mobile App help desk

Gift desk

Coffee

Exhibition

MobildApp help

desk

Luggage

Giftdesk


• Address : 201-1 Hongeun-Dong, Seodaemun-Ku, Seoul, 120-710, South Korea [ 353 Yeonhui-ro, Seodaemun-gu, Seoul, 120-710, South Korea ]• Website : http://www3.hilton.com/en/hotels/south-korea/grand-hilton-seoul-hotel-SELGRHI/index.html

• Phone : +82-2-736-1234• Address : 65-1, Gyeonji-dong, Jongno-gu, Seoul• Website : http://www.tmarkhotel.com

• Phone : +82-2-736-1234• Address : 65-1, Gyeonji-dong, Jongno-gu, Seoul• Website : http://www.aventreehotel.com

• Phone : +82-2-6730-1101• Address : 31, Samil-daero 30-gil, Jongno-gu, Seoul• Website : https://ibis.ambatelen.com/insadong/main.amb

Accommodation

Room type Special rates(Inclusive of VAT & service charge)

Hotel

Single KRW 254,100

Twin KRW 254,100

Double KRW 254,100Executive floor room

(+1 Breakfast, EFL Lounge Only) KRW 314,600

Grand Suite

2 Bedroom (3 PAX available) KRW 251,680



Breakfast (Optional) KRW 29,040

Room type Special rateDouble Weekdays (sun-thu): KRW 119,000

Weekend (fri-sat): KRW 152,000Twin

Room type Special rate

Standard twin Weekdays (sun-thu): KRW 91,500Weekend (fri-sat): KRW 102,500

Room type Special rateDouble Weekdays (sun-thu): KRW 86,000

Weekend (fri-sat): KRW 97,000Twin

▼ Grand Hilton Seoul

▼ Tmark Hotel Myeongdong

▼ Aventree Hotel Jongno

▼ ibis Ambassador Insadong


Transportation

Get on at Distance Travel time Fare

5B or12A 56 km 90 minutes Approx. USD 15For more information: http://www.airportlimousine.co.kr/


Gimpo Airport Bus Stop 19.47 km 75 minutes Approx. USD 1.2

1. Walk to the Gimpo Airport Bus Stop (2 minutes walk distance)2. Get on the Blue Line Bus # 601 at Gimpo Airport Bus Stop3. Get off at the Yousei University Bus Stop to transfer4. Get on the the Green Line # 567 which goes to the Hongeun Hyundai Apartment Bus Stop5. Get off at the Hongeun Hyundai Apartment Bus Stop6. Walk to the Venue (4 minutes walk distance)


Gimpo Int’l Airport Station 21 km 65 minutes Approx. USD 1.21. Get on the Airport Express Line at Incheon Int’l Airport Station2. Get off at the Digital Media City Station to transfer3. Get on the Line 6 (Brown) which goes to Bulgwang Station4. Get off at the Bulgwang Station to transfer5. Get on the Line 3 (Orange) which goes to Hongje Station6. Get off at the Hongje Station and go out through Exit 4 to walk to the Venue (15 minutes walk distance)


4C 56 km 60 minutes Approx. USD 60

Get on at Distance Travel time FareGimpo Int’l Airport 21 km 40 minutes Approx. USD 11

Get on at Distance Travel time

Incheon Int’l Airport 100 minutes Approx. USD 51. Get on the Airport Express Line at Incheon Int’l Airport Station2. Get off at the Digital Media City Station to transfer3. Get on the Line 6 (Brown) which goes to Bulgwang Station4. Get off at the Bulgwang Station to transfer5. Get on the Line 3 (Orange) which goes to Hongje Station6. Get off at the Hongje Station and go out through Exit 4 to walk to the Venue (15 minutes walk distance)

▼ Incheon International Airport --> Grand Hilton Seoul Hotel

▼ Gimpo International Airport --> Grand Hilton Seoul Hotel

• Airport Limousine

• Bus

• Taxi

• Taxi

• Hotel Pick-up Service

• Metro

• Metro

It is available for using Grand Hilton Hotel pick-up service. If you want the service, please book in advance through the hotel reservation department. - Fare : ICN -> HTL KRW 136,500 for 3 pax including luggage GMP -> HTL KRW 94,500 for 3 pax including luggage- Contact information Tel : +82-2-3216-5656, +82-2-2287-8427~9 / Email :[email protected], [email protected]

Korean Diabetes Association

Room 1010, Renaissance Tower Bldg., 14, Mallijae-ro, Mapo-gu, Seoul, 04195, Korea

Phone: +82-2-714-9064 / Fax: +82-2-714-9084 / E-mail: [email protected]

http://www.diabetes.or.kr

2016International

Conference onDiabetes andMetabolism

contentsicdm2016.diabetes.or.kr/file/announcement_3th.pdf · 2016-09-26 · the icdm has been...

Documents